BX Swiss TOP 30 CHF
1.370,68
PKT
-14,02
PKT
-1,01
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.10.14 | UBS overweight | JP Morgan Chase & Co. | |
| 13.10.14 | Holcim buy | Deutsche Bank AG | |
| 13.10.14 | Roche overweight | JP Morgan Chase & Co. | |
| 13.10.14 | Swiss Re buy | Jefferies & Company Inc. | |
| 13.10.14 | Roche buy | UBS AG | |
| 10.10.14 | Nestlé buy | Citigroup Corp. | |
| 09.10.14 | Nestlé Neutral | UBS AG | |
| 09.10.14 | Givaudan buy | UBS AG | |
| 09.10.14 | Holcim buy | Deutsche Bank AG | |
| 08.10.14 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 08.10.14 | Givaudan Outperform | Credit Suisse Group | |
| 08.10.14 | Novartis Hold | Deutsche Bank AG | |
| 07.10.14 | Roche buy | UBS AG | |
| 07.10.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 07.10.14 | Roche buy | Deutsche Bank AG | |
| 07.10.14 | Zurich Insurance Underperform | Bernstein Research | |
| 02.10.14 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 02.10.14 | Givaudan overweight | JP Morgan Chase & Co. | |
| 01.10.14 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 30.09.14 | UBS overweight | Morgan Stanley | |
| 30.09.14 | UBS overweight | JP Morgan Chase & Co. | |
| 29.09.14 | Roche overweight | JP Morgan Chase & Co. | |
| 29.09.14 | Roche kaufen | Independent Research GmbH | |
| 29.09.14 | UBS Underweight | JP Morgan Chase & Co. | |
| 29.09.14 | UBS Hold | Commerzbank AG | |
| 29.09.14 | UBS overweight | JP Morgan Chase & Co. | |
| 29.09.14 | Roche buy | UBS AG | |
| 26.09.14 | Roche overweight | Morgan Stanley | |
| 26.09.14 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.09.14 | Holcim buy | Deutsche Bank AG | |
| 24.09.14 | Holcim buy | Deutsche Bank AG | |
| 22.09.14 | Swiss Re Underperform | BNP PARIBAS | |
| 19.09.14 | Roche buy | Deutsche Bank AG | |
| 19.09.14 | Novartis Hold | Deutsche Bank AG | |
| 19.09.14 | Swiss Re buy | Deutsche Bank AG | |
| 18.09.14 | Givaudan buy | Nomura | |
| 18.09.14 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 18.09.14 | Holcim buy | UBS AG | |
| 18.09.14 | Holcim buy | UBS AG | |
| 17.09.14 | Nestlé Hold | Société Générale Group S.A. (SG) |